NEXT-ChemX Corporation

NEXT-ChemX Corporation owns a novel membrane-based ion extraction technology that mimics biophysical processes in nature to separate low concentrations of ions from liquid and extract them into concentrated form. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, metal ions extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is based in Austin, Texas.

NEXT-ChemX Corporation trades as CHMX on OTC. The company is classified in Industrials / Consulting Services and reports in USD.

The current profile places the business in Consulting Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $0 of revenue and -$1.81M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

NEXT-ChemX Corporation can be compared against peers such as ADF Group Inc., Austin Engineering Limited, Balyo S.A., Thruvision Group plc, Freelancer Limited, ICTS International N.V..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $316,870, beta of 1.40, and return on equity of +62.5%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CHMX currently shows total debt of $2.43M and beta of 1.40. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 8-K (2026-05-08 00:00:00), 8-K (2026-04-20 00:00:00), 8-K (2026-01-20 00:00:00), 10-Q/A (2025-11-18 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.next-chemx.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.